NMTC - NeuroOne submits FDA market application for OneRF Ablation System

2023-06-12 12:10:04 ET

Medtech developer NeuroOne Medical Technologies ( NASDAQ: NMTC ) has submitted an application for market clearance from the US Food and Drug Administration for its OneRF Ablation System for brain activity recording and tissue ablation.

Shares of NeuroOne were up 9% at $1.34 at around 12:00 p.m. ET.

NeuroOne said the system is the company's first to include hardware, software and its electrode technology. The system uses an implanted sEEG electrode to record braining activity and can be used as a RF, or radio frequency, probe to ablate nervous tissue in the brain.

The medtech company expects to receive feedback from the FDA on its application no later than Aug. 7.

More on NeuroOne:

NeuroOne Medical Technologies Corporation ( NMTC ) Q2 2023 Earnings Call Transcript

NeuroOne Medical Technologies GAAP EPS of -$0.21 misses by $0.01, revenue of $0.47M beats by $0.22M

For further details see: